Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Drug service firm Sterling is acquired by the investor GHO Capital

by Michael McCoy
March 22, 2019 | A version of this story appeared in Volume 97, Issue 12

 

The health-care investment firm GHO Capital has acquired a majority stake in Sterling Pharma Solutions, which calls itself the UK’s largest provider of active pharmaceutical ingredient development and production services. Sterling operates a facility in Northumberland, England, that was built by Sterling Drug and has been owned by several firms over the years. Sterling managers acquired it from India’s Strides Shasun in 2016, and they continue to own a stake.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.